{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:36:34Z","timestamp":1778852194375,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"12","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci. China Life Sci."],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s11427-015-4997-y","type":"journal-article","created":{"date-parts":[[2016,2,26]],"date-time":"2016-02-26T14:13:13Z","timestamp":1456495993000},"page":"1270-1281","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Autoantibody to MOG suggests two distinct clinical subtypes of NMOSD"],"prefix":"10.1007","volume":"59","author":[{"given":"Yaping","family":"Yan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaibin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minshu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aimee","family":"Borazanci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaou","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey L.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy L.","family":"Vollmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-Dong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,2,26]]},"reference":[{"key":"4997_CR1","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1056\/NEJMoa022328","volume":"349","author":"T. Berger","year":"2003","unstructured":"Berger, T., Rubner, P., Schautzer, F., Egg, R., Ulmer, H., Mayringer, I., Dilitz, E., Deisenhammer, F., and Reindl, M. (2003). Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event. N Engl J Med 349, 139\u2013145.","journal-title":"N Engl J Med"},{"key":"4997_CR2","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1172\/JCI28334","volume":"116","author":"E. Bettelli","year":"2006","unstructured":"Bettelli, E., Baeten, D., Jager, A., Sobel, R.A., and Kuchroo, V.K. (2006). Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice. J Clin Invest 116, 2393\u20132402.","journal-title":"J Clin Invest"},{"key":"4997_CR3","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1093\/brain\/123.12.2407","volume":"12","author":"R.C. d. Dale","year":"2000","unstructured":"Dale, R.C., de Sousa, C., Chong, W.K., Cox, T.C., Harding, B., and Neville, B.G. (2000). Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children. Brain 123 Pt 12, 2407\u20132422.","journal-title":"Brain 123 Pt"},{"key":"4997_CR4","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1001\/archneurol.2007.59","volume":"65","author":"R. Eichel","year":"2008","unstructured":"Eichel, R., Meiner, Z., Abramsky, O., and Gotkine, M. (2008). Acute disseminating encephalomyelitis in neuromyelitis optica: closing the floodgates. Arch Neurol 65, 267\u2013271.","journal-title":"Arch Neurol"},{"key":"4997_CR5","doi-asserted-by":"crossref","first-page":"e38896","DOI":"10.1371\/journal.pone.0038896","volume":"7","author":"L. Granieri","year":"2012","unstructured":"Granieri, L., Marnetto, F., Valentino, P., Frau, J., Patanella, A.K., Nytrova, P., Sola, P., Capobianco, M., Jarius, S., and Bertolotto, A. (2012). Evaluation of a multiparametric immunofluorescence assay for standardization of neuromyelitis optica serology. PLoS One 7, e38896.","journal-title":"PLoS One"},{"key":"4997_CR6","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-2094-9-14","volume":"9","author":"S. Jarius","year":"2012","unstructured":"Jarius, S., Ruprecht, K., Wildemann, B., Kuempfel, T., Ringelstein, M., Geis, C., Kleiter, I., Kleinschnitz, C., Berthele, A., Brettschneider, J., Hellwig, K., Hemmer, B., Linker, R.A., Lauda, F., Mayer, C.A., Tumani, H., Melms, A., Trebst, C., Stangel, M., Marziniak, M., Hoffmann, F., Schippling, S., Faiss, J.H., Neuhaus, O., Ettrich, B., Zentner, C., Guthke, K., Hofstadt-van Oy, U., Reuss, R., Pellkofer, H., Ziemann, U., Kern, P., Wandinger, K.P., Bergh, F.T., Boettcher, T., Langel, S., Liebetrau, M., Rommer, P.S., Niehaus, S., Munch, C., Winkelmann, A., Zettl, U.U., Metz, I., Veauthier, C., Sieb, J.P., Wilke, C., Hartung, H.P., Aktas, O., and Paul, F. (2012). Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients. J Neuroinflammation 9, 14.","journal-title":"J Neuroinflammation"},{"key":"4997_CR7","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/jamaneurol.2013.5055","volume":"71","author":"Y. Jiao","year":"2014","unstructured":"Jiao, Y., Fryer, J.P., Lennon, V.A., McKeon, A., Jenkins, S.M., Smith, C.Y., Quek, A.M., Weinshenker, B.G., Wingerchuk, D.M., Shuster, E.A., Lucchinetti, C.F., and Pittock, S.J. (2014). Aquaporin 4 IgG serostatus and outcome in recurrent longitudinally extensive transverse myelitis. JAMA Neurol 71, 48\u201354.","journal-title":"JAMA Neurol"},{"key":"4997_CR8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/WNO.0b013e31823c9b6c","volume":"32","author":"T. Kezuka","year":"2012","unstructured":"Kezuka, T., Usui, Y., Yamakawa, N., Matsunaga, Y., Matsuda, R., Masuda, M., Utsumi, H., Tanaka, K., and Goto, H. (2012). Relationship between NMO-antibody and anti-MOG antibody in optic neuritis. J Neuroophthalmol 32, 107\u2013110.","journal-title":"J Neuroophthalmol"},{"key":"4997_CR9","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1001\/jamaneurol.2013.3890","volume":"70","author":"J. Kitley","year":"2013","unstructured":"Kitley, J., Leite, M.I., Kuker, W., Quaghebeur, G., George, J., Waters, P., Woodhall, M., Vincent, A., and Palace, J. (2013). Longitudinally extensive transverse myelitis with and without aquaporin 4 antibodies. JAMA Neurol 70, 1375\u20131381.","journal-title":"JAMA Neurol"},{"key":"4997_CR10","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1001\/jamaneurol.2013.5857","volume":"71","author":"J. Kitley","year":"2014","unstructured":"Kitley, J., Waters, P., Woodhall, M., Leite, M.I., Murchison, A., George, J., Kuker, W., Chandratre, S., Vincent, A., and Palace, J. (2014). Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study. JAMA Neurol 71, 276\u2013283.","journal-title":"JAMA Neurol"},{"key":"4997_CR11","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1212\/WNL.0b013e31826aac4e","volume":"79","author":"J. Kitley","year":"2012","unstructured":"Kitley, J., Woodhall, M., Waters, P., Leite, M.I., Devenney, E., Craig, J., Palace, J., and Vincent, A. (2012). Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype. Neurology 79, 1273\u20131277.","journal-title":"Neurology"},{"key":"4997_CR12","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1056\/NEJMoa063602","volume":"356","author":"J. Kuhle","year":"2007","unstructured":"Kuhle, J., Pohl, C., Mehling, M., Edan, G., Freedman, M.S., Hartung, H.P., Polman, C.H., Miller, D.H., Montalban, X., Barkhof, F., Bauer, L., Dahms, S., Lindberg, R., Kappos, L., and Sandbrink, R. (2007). Lack of association between antimyelin antibodies and progression to multiple sclerosis. N Engl J Med 356, 371\u2013378.","journal-title":"N Engl J Med"},{"key":"4997_CR13","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","volume":"202","author":"V.A. Lennon","year":"2005","unstructured":"Lennon, V.A., Kryzer, T.J., Pittock, S.J., Verkman, A.S., and Hinson, S.R. (2005). IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202, 473\u2013477.","journal-title":"J Exp Med"},{"key":"4997_CR14","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s11427-015-4860-1","volume":"58","author":"J. Liu","year":"2015","unstructured":"Liu, J., Yeung, P.K., Cheng, L., Lo, A.C., Chung, S.S., and Chung, S.K. (2015). Epac2-deficiency leads to more severe retinal swelling, glial reactivity and oxidative stress in transient middle cerebral artery occlusion induced ischemic retinopathy. Sci China Life Sci 58, 521\u2013530.","journal-title":"Sci China Life Sci"},{"key":"4997_CR15","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/1742-2094-8-184","volume":"8","author":"S. Mader","year":"2011","unstructured":"Mader, S., Gredler, V., Schanda, K., Rostasy, K., Dujmovic, I., Pfaller, K., Lutterotti, A., Jarius, S., Di Pauli, F., Kuenz, B., Ehling, R., Hegen, H., Deisenhammer, F., Aboul-Enein, F., Storch, M.K., Koson, P., Drulovic, J., Kristoferitsch, W., Berger, T., and Reindl, M. (2011). Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders. J Neuroinflammation 8, 184.","journal-title":"J Neuroinflammation"},{"key":"4997_CR16","doi-asserted-by":"crossref","first-page":"13992","DOI":"10.1073\/pnas.0504979102","volume":"102","author":"C.B. Marta","year":"2005","unstructured":"Marta, C.B., Oliver, A.R., Sweet, R.A., Pfeiffer, S.E., and Ruddle, N.H. (2005). Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology. Proc Natl Acad Sci USA 102, 13992\u201313997.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4997_CR17","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1212\/WNL.0b013e3182887957","volume":"80","author":"L. Matthews","year":"2013","unstructured":"Matthews, L., Marasco, R., Jenkinson, M., Kuker, W., Luppe, S., Leite, M.I., Giorgio, A., De Stefano, N., Robertson, N., Johansen-Berg, H., Evangelou, N., and Palace, J. (2013). Distinction of seropositive NMO spectrum disorder and MSbrain lesion distribution. Neurology 80, 1330\u20131337.","journal-title":"Neurology"},{"key":"4997_CR18","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1474-4422(12)70133-3","volume":"11","author":"M.C. Papadopoulos","year":"2012","unstructured":"Papadopoulos, M.C., and Verkman, A.S. (2012). Aquaporin 4 and neuromyelitis optica. Lancet Neurol 11, 535\u2013544.","journal-title":"Lancet Neurol"},{"key":"4997_CR19","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/archneur.63.3.390","volume":"63","author":"S.J. Pittock","year":"2006","unstructured":"Pittock, S.J., Lennon, V.A., Krecke, K., Wingerchuk, D.M., Lucchinetti, C.F., and Weinshenker, B.G. (2006). Brain abnormalities in neuromyelitis optica. Arch Neurol 63, 390\u2013396.","journal-title":"Arch Neurol"},{"key":"4997_CR20","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"C.H. Polman","year":"2011","unstructured":"Polman, C.H., Reingold, S.C., Banwell, B., Clanet, M., Cohen, J.A., Filippi, M., Fujihara, K., Havrdova, E., Hutchinson, M., Kappos, L., Lublin, F.D., Montalban, X., O\u2019 Connor, P., Sandberg-Wollheim, M., Thompson, A.J., Waubant, E., Weinshenker, B., and Wolinsky, J.S. (2011). Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69, 292\u2013302.","journal-title":"Ann Neurol"},{"key":"4997_CR21","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12974-015-0256-1","volume":"12","author":"A.K. Probstel","year":"2015","unstructured":"Probstel, A.K., Rudolf, G., Dornmair, K., Collongues, N., Chanson, J.B., Sanderson, N.S., Lindberg, R.L., Kappos, L., de Seze, J., and Derfuss, T. (2015). Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype. J Neuroinflammation 12, 46.","journal-title":"J Neuroinflammation"},{"key":"4997_CR22","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00401-012-0986-4","volume":"123","author":"J. Ratelade","year":"2012","unstructured":"Ratelade, J., Zhang, H., Saadoun, S., Bennett, J.L., Papadopoulos, M.C., and Verkman, A.S. (2012). Neuromyelitis optica IgG and natural killer cells produce NMO lesions in mice without myelin loss. Acta Neuropathol 123, 861\u2013872.","journal-title":"Acta Neuropathol"},{"key":"4997_CR23","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrneurol.2013.118","volume":"9","author":"M. Reindl","year":"2013","unstructured":"Reindl, M., Di Pauli, F., Rostasy, K., and Berger, T. (2013). The spectrum of MOG autoantibody-associated demyelinating diseases. Nat Rev Neurol 9, 455\u2013461.","journal-title":"Nat Rev Neurol"},{"key":"4997_CR24","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1177\/1352458512470310","volume":"19","author":"K. Rostasy","year":"2013","unstructured":"Rostasy, K., Mader, S., Hennes, E.M., Schanda, K., Gredler, V., Guenther, A., Blaschek, A., Korenke, C., Pritsch, M., Pohl, D., Maier, O., Kuchukhidze, G., Brunner-Krainz, M., Berger, T., and Reindl, M. (2013). Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica. Mult Scler 19, 1052\u20131059.","journal-title":"Mult Scler"},{"key":"4997_CR25","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/brain\/awp309","volume":"133","author":"S. Saadoun","year":"2010","unstructured":"Saadoun, S., Waters, P., Bell, B.A., Vincent, A., Verkman, A.S., and Papadopoulos, M.C. (2010). Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. Brain 133, 349\u2013361.","journal-title":"Brain"},{"key":"4997_CR26","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/2051-5960-2-35","volume":"2","author":"S. Saadoun","year":"2014","unstructured":"Saadoun, S., Waters, P., Owens, G.P., Bennett, J.L., Vincent, A., and Papadopoulos, M.C. (2014). Neuromyelitis optica MOG-IgG causes reversible lesions in mouse brain. Acta Neuropathol Commun 2, 35.","journal-title":"Acta Neuropathol Commun"},{"key":"4997_CR27","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1212\/WNL.0000000000000101","volume":"82","author":"D.K. Sato","year":"2014","unstructured":"Sato, D.K., Callegaro, D., Lana-Peixoto, M.A., Waters, P.J., de Haidar Jorge, F.M., Takahashi, T., Nakashima, I., Apostolos-Pereira, S.L., Talim, N., Simm, R.F., Lino, A.M., Misu, T., Leite, M.I., Aoki, M., and Fujihara, K. (2014). Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Neurology 82, 474\u2013481.","journal-title":"Neurology"},{"key":"4997_CR28","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1177\/1352458514531087","volume":"20","author":"G. Tackley","year":"2014","unstructured":"Tackley, G., Kuker, W., and Palace, J. (2014). Magnetic resonance imaging in neuromyelitis optica. Mult Scler, 20, 1153\u20131164.","journal-title":"Mult Scler"},{"key":"4997_CR29","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jneuroim.2014.03.001","volume":"270","author":"M. Tanaka","year":"2014","unstructured":"Tanaka, M., and Tanaka, K. (2014). Anti-MOG antibodies in adult patients with demyelinating disorders of the central nervous system. J Neuroimmunol 270, 98\u201399.","journal-title":"J Neuroimmunol"},{"key":"4997_CR30","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1212\/WNL.0b013e318248dec1","volume":"78","author":"P.J. Waters","year":"2012","unstructured":"Waters, P.J., McKeon, A., Leite, M.I., Rajasekharan, S., Lennon, V.A., Villalobos, A., Palace, J., Mandrekar, J.N., Vincent, A., Bar-Or, A., and Pittock, S.J. (2012). Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays. Neurology 78, 665\u2013671; 669.","journal-title":"Neurology"},{"key":"4997_CR31","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1212\/WNL.0000000000000114","volume":"82","author":"B.G. Weinshenker","year":"2014","unstructured":"Weinshenker, B.G., and Wingerchuk, D.M. (2014). The two faces of neuromyelitis optica. Neurology 82, 466\u2013467.","journal-title":"Neurology"},{"key":"4997_CR32","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","volume":"6","author":"D.M. Wingerchuk","year":"2007","unstructured":"Wingerchuk, D.M., Lennon, V.A., Lucchinetti, C.F., Pittock, S.J., and Weinshenker, B.G. (2007). The spectrum of neuromyelitis optica. Lancet Neurol 6, 805\u2013815.","journal-title":"Lancet Neurol"},{"key":"4997_CR33","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jns.2013.08.034","volume":"335","author":"M. Woodhall","year":"2013","unstructured":"Woodhall, M., Coban, A., Waters, P., Ekizoglu, E., Kurtuncu, M., Shugaiv, E., Turkoglu, R., Akman-Demir, G., Eraksoy, M., Vincent, A., and Tuzun, E. (2013). Glycine receptor and myelin oligodendrocyte glycoprotein antibodies in Turkish patients with neuromyelitis optica. J Neurol Sci 335, 221\u2013223.","journal-title":"J Neurol Sci"},{"key":"4997_CR34","doi-asserted-by":"crossref","first-page":"19057","DOI":"10.1073\/pnas.0607242103","volume":"103","author":"D. Zhou","year":"2006","unstructured":"Zhou, D., Srivastava, R., Nessler, S., Grummel, V., Sommer, N., Bruck, W., Hartung, H.P., Stadelmann, C., and Hemmer, B. (2006). Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis. Proc Natl Acad Sci USA 103, 19057\u201319062.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Science China Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-015-4997-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-015-4997-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T01:24:43Z","timestamp":1567646683000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11427-015-4997-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,26]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["4997"],"URL":"https:\/\/doi.org\/10.1007\/s11427-015-4997-y","relation":{},"ISSN":["1674-7305","1869-1889"],"issn-type":[{"value":"1674-7305","type":"print"},{"value":"1869-1889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,26]]}}}